![]() |
Trials |
A phase II trial of ibrutinib, lenalidomide and rituximab for patients with relapsed/refractory mantle cell lymphomaCancer type: Lymphoma Phase: II Principal Investigator: Bentzen Hans Country: DK Keywords: Denmark, Aarhus Status: Inclusion completed Link to Clinicaltrials.gov: EudraCT no. 2013-005541-36 |